These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8071039)

  • 1. Principles and aims of preclinical testing.
    Speck U
    Invest Radiol; 1994 May; 29 Suppl 1():S15-20. PubMed ID: 8071039
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical characterization of iopromide.
    Krause W
    Invest Radiol; 1994 May; 29 Suppl 1():S21-32. PubMed ID: 8071040
    [No Abstract]   [Full Text] [Related]  

  • 3. Iopamidol a new contrast agent in angiocardiography. Experimental and clinical experience in comparison with a commonly used contrast medium.
    Niccoli L; Bellandi M; Benedini G; Cucchini F; Ettori F; Leonzi O; Visioli O
    Radiol Med; 1986 Jun; 72(6 Suppl 1):32-6. PubMed ID: 3726197
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new contrast medium emulsion for lymphography (author's transl)].
    Roth SL; Dombrowski H; Hiort U; Kalbfleisch H; Ludwig K; Siefart F; Seher A; Vielhauer E
    Rofo; 1979 Sep; 131(3):317-21. PubMed ID: 161269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of iopamidol and diatrizoate with iotrolan as a contrast medium for radiographic gastrointestinal tract examinations.
    Miyazawa T; Murayama C; Ozawa M; Fritz-Zieroth B
    Invest Radiol; 1991 Nov; 26 Suppl 1():S182-4; discussion S185. PubMed ID: 1808122
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical profile of Gd-BOPTA. A liver-specific MRI contrast agent.
    Vittadini G; Felder E; Musu C; Tirone P
    Invest Radiol; 1990 Sep; 25 Suppl 1():S59-60. PubMed ID: 2283258
    [No Abstract]   [Full Text] [Related]  

  • 7. Albunex--a new ultrasound contrast agent. Effects on hemodynamics, contrast, and biodistribution in different species.
    Walday P; Ostensen J; Tolleshaug H; Holtz E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S142-4. PubMed ID: 7928211
    [No Abstract]   [Full Text] [Related]  

  • 8. Choice of contrast medium in sialography.
    Verhoeven JW
    Oral Surg Oral Med Oral Pathol; 1984 Mar; 57(3):323-37. PubMed ID: 6584822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal experiments and clinical experiences in cerebral angiography with a new contrast agent (ioxaglic acid) with a low hyperosmolality.
    Gonsette RE
    Ann Radiol (Paris); 1978; 21(4-5):271-3. PubMed ID: 718079
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance of the kidneys to the contrast medium urografin.
    SMIDDY FG; ANDERSON GK
    Br J Urol; 1960 Jun; 32():156-9. PubMed ID: 13831805
    [No Abstract]   [Full Text] [Related]  

  • 11. [Does TrasylolR (Bayer) influence the tolerance of aequous iodated contrast substances (author's transl)].
    Svoboda M; Puchta V
    Cesk Radiol; 1975 Jul; 29(4):270-2. PubMed ID: 1080083
    [No Abstract]   [Full Text] [Related]  

  • 12. Iotasul, a water-soluble contrast agent for direct and indirect lymphography. Results of preclinical investigations.
    Siefert HM; Mützel W; Schöbel C; Weinmann HJ; Wenzel-Hora BI; Speck U
    Lymphology; 1980 Sep; 13(3):150-7. PubMed ID: 6777611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of contrast medium dosage, picture quality and tolerance].
    Pokieser H; Umek H
    Rontgenpraxis; 1972 Feb; 25(2):34-8. PubMed ID: 5020125
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ionic and non-ionic contrast media].
    Bryc S
    Ann Univ Mariae Curie Sklodowska Med; 1986; 41():145-56. PubMed ID: 3154050
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined methods for assessment of neurotoxicity: testing of new nonionic radiographic media.
    Sovak M; Siefert HM; Ranganathan R
    Invest Radiol; 1980; 15(6 Suppl):S248-53. PubMed ID: 7203930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of fluorescein.
    Roy JJ; Lau A; McFee DG
    CMAJ; 1998 Feb; 158(4):471. PubMed ID: 9627556
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical testing of iopromide. 1st communication: pharmacological evaluation.
    Krause W; Press WR; Frenzel T
    Arzneimittelforschung; 1994 Oct; 44(10):1162-6. PubMed ID: 7529504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of extracellular contrast agents for magnetic resonance imaging.
    Weinmann HJ; Press WR; Gries H
    Invest Radiol; 1990 Sep; 25 Suppl 1():S49-50. PubMed ID: 2283256
    [No Abstract]   [Full Text] [Related]  

  • 19. [ Use of N-acetylcysteine for the prevention of contrast-induced nephropathy in rats].
    Inci MF; Salk I; Solak O; Vurdem UE; Inci R
    Actas Urol Esp; 2012 Apr; 36(4):210-5. PubMed ID: 22548227
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nonionogenic x-ray contrast substances. An experimental and clinical evaluation].
    Sviridov NK
    Farmakol Toksikol; 1984; 47(4):109-16. PubMed ID: 6383860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.